Novo Nordisk Aktie
42,10
EUR
+0,35
EUR
+0,83
%
42,20
EUR
+0,38
EUR
+0,90
%
Novo Nordisk jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Novo Nordisk Aktie Analyse
| 26.05.16 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 23.05.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 04.05.16 | Novo Nordisk buy | Citigroup Corp. | |
| 03.05.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 02.05.16 | Novo Nordisk overweight | Barclays Capital | |
| 29.04.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 26.04.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 22.04.16 | Novo Nordisk overweight | Morgan Stanley | |
|
Werbung
|
|||
| 18.04.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 29.03.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 22.03.16 | Novo Nordisk overweight | Morgan Stanley | |
| 07.03.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 07.03.16 | Novo Nordisk overweight | Morgan Stanley | |
| 07.03.16 | Novo Nordisk buy | Citigroup Corp. | |
| 07.03.16 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 02.03.16 | Novo Nordisk buy | Citigroup Corp. | |
| 24.02.16 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 24.02.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 15.02.16 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 04.02.16 | Novo Nordisk overweight | Barclays Capital | |
| 04.02.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 01.02.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 01.02.16 | Novo Nordisk buy | Citigroup Corp. | |
| 01.02.16 | Novo Nordisk overweight | Morgan Stanley | |
| 01.02.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 26.01.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 21.01.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 08.01.16 | Novo Nordisk overweight | Barclays Capital | |
| 07.01.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 06.01.16 | Novo Nordisk overweight | Morgan Stanley | |
| 02.12.15 | Novo Nordisk overweight | Morgan Stanley | |
| 25.11.15 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 20.11.15 | Novo Nordisk buy | Citigroup Corp. | |
| 20.11.15 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 20.11.15 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 19.11.15 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 17.11.15 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 03.11.15 | Novo Nordisk buy | Citigroup Corp. | |
| 30.10.15 | Novo Nordisk overweight | Morgan Stanley | |
| 29.10.15 | Novo Nordisk buy | Citigroup Corp. | |
| 26.10.15 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 21.10.15 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 28.09.15 | Novo Nordisk buy | Citigroup Corp. | |
| 28.09.15 | Novo Nordisk overweight | Morgan Stanley | |
| 28.09.15 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 28.09.15 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 04.09.15 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 27.08.15 | Novo Nordisk overweight | Morgan Stanley | |
| 27.08.15 | Novo Nordisk buy | Citigroup Corp. | |
| 27.08.15 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
Werbung
Werbung